Published in J Am Acad Dermatol on January 20, 2011
Gene expression profiling of the leading edge of cutaneous squamous cell carcinoma: IL-24-driven MMP-7. J Invest Dermatol (2013) 1.50
Combined cetuximab and volumetric modulated arc-radiotherapy in advanced recurrent squamous cell carcinoma of the scalp. Dermatol Reports (2011) 1.03
'This isn't what mine looked like': a qualitative study of symptom appraisal and help seeking in people recently diagnosed with melanoma. BMJ Open (2014) 0.97
Advanced basal cell carcinoma, the hedgehog pathway, and treatment options - role of smoothened inhibitors. Biologics (2015) 0.85
Squamous cell carcinoma: variation in dermatoscopic vascular features between well and non-well differentiated tumors. Dermatol Pract Concept (2012) 0.83
Expression of nuclear survivin in normal skin and squamous cell carcinoma: a possible role in tumour invasion. Br J Cancer (2013) 0.80
Squamous cell carcinoma with aggressive subclinical extension: 5-year retrospective review of diagnostic predictors. J Am Acad Dermatol (2015) 0.78
Modified Tumor Classification With Inclusion of Tumor Characteristics Improves Discrimination and Prediction Accuracy in Oral and Hypopharyngeal Cancer Patients Who Underwent Surgery. Medicine (Baltimore) (2015) 0.78
The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients. J Am Acad Dermatol (2012) 0.77
Differential expression of degradome components in cutaneous squamous cell carcinomas. Mod Pathol (2013) 0.77
Expression of FOXC2, PinX1, Ki-67 and Cyclin D1 in cutaneous cell carcinoma. Oncol Lett (2017) 0.75
Tumors of the hand. Eur J Orthop Surg Traumatol (2017) 0.75
Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49
Cutaneous squamous-cell carcinoma. N Engl J Med (2001) 7.31
Skin cancers after organ transplantation. N Engl J Med (2003) 6.65
SQUAMOUS-CELL EPITHELIOMA OF THE SKIN: A STUDY OF 256 CASES. Ann Surg (1921) 4.59
Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol (1992) 4.13
The epidemiology of skin cancer. Br J Dermatol (2002) 4.07
Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol (2008) 3.71
Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol (1999) 3.19
Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg (2002) 1.87
Mortality risk from squamous cell skin cancer. J Clin Oncol (2005) 1.74
Perineural invasion in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg (1998) 1.66
Epidermoid carcinoma of the hand. Cancer (1950) 1.60
Metastases from squamous cell carcinoma of the skin and lip. An analysis of twenty-seven cases. J Am Acad Dermatol (1989) 1.56
Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg (1984) 1.47
Reporting tumor thickness for cutaneous squamous cell carcinoma. J Cutan Pathol (2002) 1.44
Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet (1989) 1.34
Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg (2007) 1.29
Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope (2005) 1.27
Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck (2002) 1.23
Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer (2006) 1.22
UV dose determines key characteristics of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.21
Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol (2006) 1.18
Metastases from squamous cell carcinoma of the skin in southern Australia. Dermatology (1994) 1.18
Changing trends in non-melanoma skin cancer in South Wales, 1988-98. Br J Dermatol (2000) 1.14
Incidence rates of skin cancer in Townsville, Australia. Int J Cancer (1998) 1.13
Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis. Cancer (1997) 1.13
Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol (2003) 1.09
Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer (1999) 1.09
Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma. J Plast Reconstr Aesthet Surg (2006) 1.07
Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer. Cancer (1997) 1.06
Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck (2007) 1.06
Perineural invasion of cutaneous malignancies. Dermatol Surg (2001) 1.03
Carcinoma of the skin with perineural invasion. Head Neck (2003) 1.02
High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer (2006) 0.97
Microstaging of squamous cell carcinomas. Am J Clin Pathol (1990) 0.97
High-risk cutaneous squamous cell carcinoma of the head and neck. J Biomed Biotechnol (2007) 0.96
Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): a better outcome with surgery and adjuvant radiotherapy. Laryngoscope (2003) 0.96
Cutaneous metastatic squamous cell carcinoma to the parotid gland: analysis and outcome. Head Neck (2004) 0.95
Evaluation of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma and proposal of a new staging system. Dermatol Surg (2005) 0.94
Risk factors related to locoregional recurrence in squamous cell carcinoma of the skin. J Surg Oncol (1996) 0.92
Regional lymph node metastasis from cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (1998) 0.91
Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer (1985) 0.90
Extent of parotid disease influences outcome in patients with metastatic cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2003) 0.90
Histopathological characteristics of metastasizing squamous cell carcinoma of the skin and lips. Histopathology (2006) 0.90
Malignancy. Surg Clin North Am (1994) 0.87
Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion. J Am Acad Dermatol (2005) 0.87
Squamous cell carcinoma. A population-based incidence study in Rochester, Minn. Arch Dermatol (1990) 0.87
Squamous cell carcinoma of skin with perineural invasion. J Am Acad Dermatol (1994) 0.84
Lymph node metastasis in lower lip squamous cell carcinoma in relation to tumour size, histologic variables and p27Kip1 protein expression. Oral Oncol (2004) 0.80
Problems in the current TNM staging of nonmelanoma skin cancer of the head and neck. Head Neck (2007) 0.77
Prognosis in lower lip squamous cell carcinoma: assessment of tumor factors. Pathol Res Pract (1998) 0.76
Squamous cell carcinoma of the head and neck in solid organ transplant recipients. Head Neck (2002) 0.76
The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg (2007) 0.76
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med (2012) 52.99
Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol (2010) 17.13
Efficient tumour formation by single human melanoma cells. Nature (2008) 16.35
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (2011) 11.12
Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. J Clin Oncol (2014) 9.86
Management of cutaneous melanoma. N Engl J Med (2004) 9.52
Melanoma. N Engl J Med (2006) 8.80
TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med (2007) 5.92
Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA (2005) 5.52
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci U S A (2003) 5.49
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nat Med (2010) 4.81
ATR regulates fragile site stability. Cell (2002) 4.74
Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol (2008) 4.69
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proc Natl Acad Sci U S A (2008) 4.43
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab (2005) 4.39
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell (2012) 4.04
Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell (2010) 3.70
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody. Clin Cancer Res (2012) 3.68
Special report: suicidal ideation among American surgeons. Arch Surg (2011) 3.53
Prevalence of alcohol use disorders among American surgeons. Arch Surg (2012) 3.53
Burnout and medical errors among American surgeons. Ann Surg (2010) 3.44
Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists. J Cutan Pathol (2004) 3.43
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA (2013) 3.38
Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer (2005) 3.27
Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol (2002) 3.20
Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature. Arch Dermatol (2006) 2.92
Burnout and career satisfaction among American surgeons. Ann Surg (2009) 2.87
Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol (2010) 2.83
Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol (2003) 2.81
Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol (2008) 2.80
Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol (2007) 2.72
Melanoma information on the Internet: often incomplete--a public health opportunity? J Clin Oncol (2002) 2.61
Alcohol consumption and expenditures for underage drinking and adult excessive drinking. JAMA (2003) 2.59
Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol (2006) 2.58
High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg (2003) 2.56
MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer (2008) 2.56
Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol (2011) 2.52
Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol (2004) 2.42
Temporal dissection of tumorigenesis in primary cancers. Cancer Discov (2011) 2.40
De novo intraepidermal epithelioid melanocytic dysplasia as a marker of the atypical mole phenotype -- a clinical and pathological study of 75 patients. J Cutan Pathol (2005) 2.38
Impact of pharyngeal closure technique on fistula after salvage laryngectomy. JAMA Otolaryngol Head Neck Surg (2013) 2.37
An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature (2012) 2.35
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol (2010) 2.30
Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol (2004) 2.29
Integration of growth factor and nutrient signaling: implications for cancer biology. Mol Cell (2003) 2.29
Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R. J Biol Chem (2003) 2.26
In-transit melanoma: an individualized approach. Oncology (Williston Park) (2011) 2.24
Pyoderma gangrenosum: a review. J Cutan Pathol (2003) 2.23
Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol (2005) 2.22
Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst (2009) 2.22
Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients. Cancer Res (2010) 2.14
Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol (2005) 2.12
Prospective functional voice assessment in patients undergoing thyroid surgery. Ann Surg (2002) 2.08
Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst (2008) 2.08
Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells. J Biol Chem (2008) 2.07
Electrosurgery and implantable electronic devices: review and implications for office-based procedures. Dermatol Surg (2011) 2.07
Primary mucosal malignant melanoma of the head and neck. Head Neck (2002) 2.07
Confocal reflectance mosaicing of basal cell carcinomas in Mohs surgical skin excisions. J Biomed Opt (2007) 2.04
Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid (2014) 2.04
TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin (2005) 2.03
Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. J Clin Oncol (2012) 2.02
Thyroid carcinoma. J Natl Compr Canc Netw (2010) 2.02
Financial Conflicts of Interest: An Association between Funding and Findings in Plastic Surgery. Plast Reconstr Surg (2015) 2.00
DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage. Int J Cancer (2007) 1.97
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. J Clin Oncol (2006) 1.97
Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation. Clin Cancer Res (2002) 1.97
Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon. Head Neck (2008) 1.97
Memory regulatory T cells reside in human skin. J Clin Invest (2014) 1.95
Craniofacial surgery for malignant skull base tumors: report of an international collaborative study. Cancer (2003) 1.94
Confocal mosaicing microscopy in Mohs skin excisions: feasibility of rapid surgical pathology. J Biomed Opt (2008) 1.94
Unusual variants of malignant melanoma. Mod Pathol (2006) 1.93
Relationship between work-home conflicts and burnout among American surgeons: a comparison by sex. Arch Surg (2011) 1.90
Sentinel-node biopsy in melanoma. N Engl J Med (2006) 1.90
Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute. Melanoma Res (2005) 1.87
ATR-Chk1 pathway inhibition promotes apoptosis after UV treatment in primary human keratinocytes: potential basis for the UV protective effects of caffeine. J Invest Dermatol (2009) 1.86
BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res (2006) 1.85
Avoiding burnout: the personal health habits and wellness practices of US surgeons. Ann Surg (2012) 1.85
Connective tissue remodeling induced by carbon dioxide laser resurfacing of photodamaged human skin. Arch Dermatol (2004) 1.85
The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer (2009) 1.85
The mutational landscape of adenoid cystic carcinoma. Nat Genet (2013) 1.83
Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer (2007) 1.83
Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2011) 1.80
Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer (2006) 1.79
Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol (2011) 1.78
Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys (2010) 1.77
Nipple-sparing mastectomy: critical assessment of 51 procedures and implications for selection criteria. Ann Surg Oncol (2008) 1.77